Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 8 December 2017, 10:47 HKT/SGT
Share:
    

Source: Hitachi, Ltd.
Hitachi and Mitsubishi Electric Agree to Integrate Particle Therapy System Business

TOKYO, Dec 8, 2017 - (JCN Newswire) - Hitachi, Ltd. (TSE:6501) and Mitsubishi Electric Corporation (TSE:6503) today announced that they have signed an agreement to transfer Mitsubishi Electric's particle therapy system business to Hitachi and integrate to one entity. After their negotiation and the review and approval from the relevant authorities, the design, manufacturing, sales, maintenance services relevant to Mitsubishi Electric's particle therapy system business will be merged into Hitachi, currently scheduled for April 2018.

Particle therapy is being noticed as one of the effective treatment methods due to the side effects of treatment are few compared with other cancer treatment methods such as surgical treatment and rehabilitation after treatment is also relatively fast. There are currently more than 70 particle therapy system facilities in operation worldwide and the numbers are rapidly increasing since 2013 expecting that over 10 facilities will be newly constructed each year. In Japan, proton therapy for pediatric cancer and heavy particle radiation treatment for bone and soft tissue tumor have been recognized and accepted as one of the cancer treatment methods as it has been approved to be covered by national insurance since April 2016.

Hitachi received an order from 13 prestigious hospitals in Japan, North America and Asia for the particle therapy system, of which 8 facilities are in operation. Hitachi provides superior particle therapy systems over the world. More than 16,000 patients have been treated with the systems and Hitachi has established a reputation of high reliability with a proven track record. In addition, Hitachi continues to make particle therapy systems popular by joint research about radiation therapy with an advanced cancer hospital in America.

Mitsubishi Electric supplies the particle therapy system for 9 of the 17 medical institutions where particle therapy and clinical research are conducted in Japan. Mitsubishi Electric has made particle therapy popular by supporting operation such as staff training to operate particle therapy systems and communication among medical institutions as well as providing systems.

Hitachi and Mitsubishi Electric both agree that it is necessary to enhance product competitiveness through integration of development and resources, and to provide products and services with higher performance with higher added value as the particle therapy expands globally. After numerous consideration, the parties concluded that integration through business transfer to Hitachi, which is developing a wide range of healthcare businesses, is the best option, and thus have come to an agreement. Hitachi will utilize the technology with their experience in particle therapy system and contribute in providing cutting edge radiation therapy.

About Mitsubishi Electric Corporation

With over 90 years of experience in providing reliable, high-quality products, Mitsubishi Electric Corporation (TOKYO: 6503) is a recognized world leader in the manufacture, marketing and sales of electrical and electronic equipment used in information processing and communications, space development and satellite communications, consumer electronics, industrial technology, energy, transportation and building equipment. Embracing the spirit of its corporate statement, Changes for the Better, and its environmental statement, Eco Changes, Mitsubishi Electric endeavors to be a global, leading green company, enriching society with technology. The company recorded consolidated group sales of 4,238.6 billion yen (US$ 37.8 billion) in the fiscal year ended March 31, 2017. For more information visit: http://www.MitsubishiElectric.com.


About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society's challenges with our talented team and proven experience in global markets. The company's consolidated revenues for fiscal 2014 (ended March 31, 2015) totaled 9,761 billion yen ($81.3 billion). Hitachi is focusing more than ever on the Social Innovation Business, which includes power & infrastructure systems, information & telecommunication systems, construction machinery, high functional materials & components, automotive systems, healthcare and others. For more information on Hitachi, please visit the company's website at www.hitachi.com.

Contact:
Hitachi Ltd
Corporate Communications
Tel: +81-3-3258-1111


Dec 8, 2017 10:47 HKT/SGT
Source: Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501)

Topic: Press release summary
Sectors: Electronics
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2018 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Hitachi, Ltd.
Jan 18, 2018 15:42 HKT/SGT
Hitachi to Introduce New Innovations for Realizing Utility 3.0 via the Lumada IoT Platform at DistribuTECH 2018
Jan 16, 2018 13:29 HKT/SGT
Hitachi to Continue Team Penske Partnership in 2018
Jan 10, 2018 09:32 HKT/SGT
Hitachi to Expand its Clinical Reporting and Analytics for Diagnostic Imaging with the Acquisition of VidiStar
Jan 10, 2018 09:00 HKT/SGT
Hitachi Automotive Systems and Clarion Announce the Development of "Park-by-Memory"
Jan 10, 2018 08:34 HKT/SGT
Hitachi to Feature Advanced Mobility Technologies and Recruit Engineers at the 2018 NAIAS
Dec 15, 2017 13:38 HKT/SGT
Hitachi to Install New Proton Beam Therapy System in Spain
Dec 15, 2017 09:59 HKT/SGT
UK ABWR Successfully Completes GDA Process
Dec 14, 2017 11:39 HKT/SGT
Hitachi Promotes ASEAN Business Strategy at Board of Directors Meeting in Singapore
Dec 14, 2017 11:03 HKT/SGT
Partners Connected Health and Hitachi Develop an Explainable Ai Technology to Help Doctors Predict Readmissions and Improve Patient Outcomes
Dec 11, 2017 13:22 HKT/SGT
Hitachi Invests in Preferred Networks
More news >>
 News Alerts
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6721 7212

Connect With us: